Nabumetone
- Product NDC
- 68071-5166
- 11-digit product format
- 680715166
- Labeler code
- 68071
- Product ID
- 68071-5166_bbf611c6-17d4-485d-e053-2a95a90a6b16
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Nabumetone
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- NuCare Pharmaceuticals,Inc.
- Application
- ANDA078420
- Marketing category
- ANDA
- Marketing start
- 2019-06-26
- Marketing end
- 0000-00-00
- Substance
- NABUMETONE
- Active strength
- 500 mg/1
- Pharmacologic classes
- Cyclooxygenase Inhibitors [MoA],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 68071-5166-6 | 68071516606 | 60 TABLET in 1 BOTTLE (68071-5166-6) | 60 tablet | 2020-02-06 | 0000-00-00 | No | No | Current |